cholesterol

American Vasant Narasimhan, CEO of Swiss pharmaceutical and drug maker Novartis speaks during a conference at the Coins2Day Global Forum event in Paris on Nov. 18, 2019. (Photo by ERIC PIERMONT / AFP) (Photo by ERIC PIERMONT/AFP via Getty Images)
International

Novartis Bets Big on Cholesterol Drug With $9.7 Billion Buyout of Medicines Co.

By James Paton and Bloomberg
November 25, 2019
USA - Business - Amgen Headquarters in Thousand Oaks
Health

Why Amgen Is Lowering the Price of Cholesterol Drug Repatha By 60%

By
October 25, 2018
Could a Vaccine Prevent High Cholesterol and Heart Disease?
Health

Could a Vaccine Prevent High Cholesterol and Heart Disease?

By
June 20, 2017
Cheese Platter
Health

There Is No Reason to Even Consider Eating Reduced Fat Cheese, Says Science

By Danica Lo and Food & Wine
September 21, 2016
155292424
Health

Another Major Insurer Is Tying Drug Prices to Health Outcomes

By
May 11, 2016
An Amgen sign is seen at the company's office in South San Francisco
Health

Amgen Just Won a Major Drug Patent Case Against Its Rivals

By
March 16, 2016

Most Popular